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Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NebraskaABSTRACT Mechanisms underlying the initiation and persistence of lethal cardiac rhythms are of significant clinical and
scientific interests. Gap junctions are principally involved in forming the electrical connections between myocytes, and changes
in distribution, density, and properties are consistent characteristics in arrhythmic heart disease. Therefore, understanding the
structure and function of gap junctions during normal and abnormal impulse propagation are essential in the control of arrhyth-
mias. For example, Cx45 is predominately expressed in the specialized myocytes of the impulse generation and conduction
system. In both ventricular and atrial human working myocytes, Cx45 is present in very low quantities. However, a reduction
in Cx43 coupled with an increased Cx45 protein levels within the ventricles have been observed after myocardial infarction
and end-stage heart failure. Cx45 may influence electrical and/or metabolic coupling as a result of pathophysiological over-
expression. Our goal was to identify mechanisms that could cause cellular coupling to be different between the cardiac con-
nexins. Based upon the conserved transmembrane and extracellular loop segments, our focus was on identifying features
within the divergent cytoplasmic portions. Here, we biophysically characterize the carboxyl-terminal domain of Cx45
(Cx45CT). Purification revealed the possibility of oligomeric species, which was confirmed by analytical ultracentrifugation ex-
periments. Sedimentation equilibrium and circular dichroism studies of different Cx45CT constructs identified one region of
a-helical structure (A333-N361) that mediates CT dimerization through hydrophobic contacts. Interestingly, the binding affinity
of Cx45CT dimerization is 1000-fold stronger than Cx43CT dimerization. Cx45CT resonance assignments were also used to
identify the binding sites and affinities of molecular partners involved in the Cx45 regulation; although none disrupted dimeriza-
tion, many of these proteins interacted within one intrinsically disordered region (P278-P285). This domain has similarities with
other cardiac connexins, and we propose they constitute a master regulatory domain, which contains overlapping molecular
partner binding, cis-trans proline isomerization, and phosphorylation sites.INTRODUCTIONGap junctions are conglomerates of cell-to-cell channels
that allow for the direct exchange of ions and low molecular
mass metabolites (<1 kDa) between adherent cells. They
provide a pathway for the propagation and/or amplification
of signal transduction cascades triggered by cytokines,
growth factors, and other cell signaling molecules involved
in growth and development. Gap junction channels are
created by the apposition of connexons from adjacent cells,
in which each connexon is formed by six connexin proteins.
There are 21 different human connexin isoforms named
according to their molecular mass (e.g., 45 kDa isoform is
Cx45) with differential spatial-temporal tissue expression
(1). For example, Cx45, Cx43, and Cx40 are found in
distinct combinations and relative quantities in different,
functionally specialized subsets of cardiomyocytes (2). In
the diseased heart, expression levels of these cardiac
connexins are altered, which can lead to abnormal impulse
propagation and generation of ventricular arrhythmias, pre-
disposing patients to heart failure (3–5). Even though there
is a significant amount of sequence homology between the
connexins, the major divergence in primary structures,
which helps confer specific regulatory properties for eachSubmitted October 1, 2013, and accepted for publication March 31, 2014.
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nal (CT) domains.
The CT domain plays a role in the trafficking, size, local-
ization, and turnover of gap junctions, as well as the level
of intercellular coupling via numerous posttranslational
modifications and protein-protein interactions (6–8). Struc-
tural studies of Cx43 and Cx26 gap junctional channels,
which used cryo-electron microscopy and x-ray crystallog-
raphy techniques, respectively, provided a significant
amount of information about channel architecture (9,10).
Unfortunately, neither technique was able to determine the
CT structure because of its dynamic nature. More amend-
able biophysical techniques, such as NMR and circular di-
chroism (CD), have been used to study the CT domain.
NMR was used to assign the resonances of the soluble
Cx43CT (S255-I382) and Cx40CT (S251-V355) domains
and determined they are predominantly intrinsically disor-
dered in structure (11–14). This information was used to
map the binding sites, calculate the binding affinities of
molecular partners, and determine the effects of pH and
phosphorylation on these interactions (13–17). Together
with biophysical studies of the Cx43CT and Cx40CT
domains from other laboratories, mechanisms involved in
channel gating and protein turnover have been identified
(18–26). To date, little information exists for the CT domain
from the Cx45 isoform (Cx45CT; (27,28)). Therefore, wehttp://dx.doi.org/10.1016/j.bpj.2014.03.045
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domain and its interactions with molecular partners
involved in gap junction regulation. The information pro-
vided herein offers a better understanding of the similarities
and differences in structure and binding of protein partners
between the cardiac connexin CT domains that can be ex-
ploited to aid in the design of chemical modifiers to regulate
the function of gap junctions.MATERIAL AND METHODS
Cloning, expression, and purification of the
Cx45CT domain, truncation A333-N361, Cx45 4th
transmembrane (TM4) domain, and Cx45CT
attached to the TM4 domain
DNA encoding the Cx45CT (K265-I396) and the Cx45CT attached to the
4th transmembrane domain (TM4-Cx45CT; D219-I396) were cloned using
polymerase chain reaction from a BlueScribe SK vector containing theMus
musculus Cx45 gene (gift from Dr. Steven M. Taffet) into the bacterial
expression vector pGEX-KT (gift from Dr. Gregory S. Taylor) and pET-
14b (Novagen; Madison, WI), respectively. The plasmid sequences (and
others described below) were verified at the University of Nebraska
Medical Center DNA Sequencing Core Facility. The domain boundary
for the Cx45CT begins at K265, placing this residue close but outside of
the TM4 (transmembrane prediction programs: http://www.cbs.dtu.dk/
services/TMHMM/ and http://www.ch.embnet.org/software/TMPRED_
form.html). The protocols used to express and purify the Cx45CT and
TM4-Cx45CT domains were previously described (27,28). The TM4
domain was purified using the same procedures as the TM4-Cx45CT.
Unless noted, the final buffer condition used in all experiments was 1
phosphate buffered saline (PBS) buffer at pH 5.8 and 25C for the
Cx45CT domain and 20 mM MES, 50 mM NaCl, 8% w/v 1-palmitoyl-2-
hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] (LPPG; Avanti Lipids;
Alabaster, AL), 1 mM DTT, and 1 mM EDTA at pH 5.8 and 42C for
the TM4 and TM4-Cx45CT domains.
Cx45CT residues A333-N361 were cloned using polymerase chain reac-
tion from the Cx45CT K265-I396 construct into the pGEX-KT vector. The
boundaries were chosen based on the Cx45CT residues that broadened
beyond detection in the 15N-HSQC experiment (27). The polypeptide was
transformed with Rosetta 2(DE3)pLysS cells (Novagen), grown in either
Luria Broth (LB) or 15N-labeled minimal media, and induced with
0.5 mM IPTG (final concentration) at a cell density of 0.6 OD600 for 4 h.
The bacterial cells were pelleted and resuspended in 1 PBS, 1 mM
PMSF, 1% v/v NP-40, and Complete Protease Inhibitor (Roche Molecular
Biochemicals; Mannheim, Germany). The cells were lysed using a French
Press and the lysate was cleared by centrifugation (16,500 rpm, 1 h). The
GST-tagged Cx45CT A333-N361 domain was incubated with GST resin
(GenScript; Piscataway, NJ) for 2 h at 4C and cleaved from the GST-tag
by incubation with thrombin overnight. The Cx45CT A333-N361 was
then incubated with benzamidine resin (GE Healthcare; Pittsburgh, PA)
and concentrated using Amicon Ultra 3 K and 30 K filters (Millipore;
San Diego, CA). The final buffer condition used (unless noted) was 1
PBS buffer at pH 5.8 and 25C.Expression and purification of other GST-tagged
proteins
Protein domains cloned in the pGEX-KT vector include neural precursor
cell expressed developmentally downregulated protein 4 (Nedd4) WW2
(D392-S458) domain (gift from Dr. Daniela Rotin) and c-Src Src Homology
3 (SH3, G81-V147) domain (14,15). Protein domains cloned into thepGEX-6P-2 vector include Dynamin 2 (Dyn2; gift from Dr. Steve Caplan)
pleckstrin homology (PH; V520-K629) domain, Cx43CT (V236-I382), and
Cx40CT (S251-V355) (12,14,17,29). These proteins were expressed using
BL21(DE3) competent cells (Life Technologies) and purified using tech-
niques described previously for the Cx45CT A333-N361 construct. To
cleave the protein of interest from GST, beads were incubated overnight
at 4C with thrombin (pGEX-KT vector) or Turbo3C (Accelagen; San
Diego, CA; pGEX-6P-2 vector).Cloning, expression, and purification of His-
tagged proteins
The ZO-1 PDZ-2 (T185-E264) domain was cloned into the pET-14b vector
(14,15,30). DNA containing the tumor susceptibility gene 101 (TSG101)
Ubiquitin E2 Variant (UEV, M1-P145) domain in the pET-28a vector was
a gift from Dr. Kay-Uwe Wagner. After expression using BL21(DE3) cells
as described previously for GST-tagged proteins, the bacterial cell pellet
was resuspended in 1 PBS, 20 mM imidazole, and 1 mM b-mercaptoetha-
nol at pH 5.8 with protease inhibitor cocktail (Sigma Aldrich; St. Louis,
MO), then lysed three times using the French Press. The lysate was cleared
by centrifugation (17,500 rpm, 1 h, 4C). The supernatant was loaded onto
an A¨KTA FPLC using a HisTrap HP column (GE Healthcare). Protein
elution was accomplished using a gradient (0–100%) of 1 PBS, 1 M imid-
azole, and 1 mM b-mercaptoethanol at pH 5.8. Fractions containing puri-
fied protein were verified by SDS-PAGE, pooled, and dialyzed overnight
at 4C against 1 PBS with 1 mM DTT at pH 5.8 using a 3 kDa cut-off
Slide-A-Lyzer dialysis cassette (Pierce; Rockford, IL).Expression and purification of calmodulin
DNA encoding calmodulin (CaM) in the pAED7 vector was a gift from Dr.
Katalin To¨ro¨k. The protocol used to express and purify CaM was previously
described (31,32). After purification, CaM was lyophilized and stored
at 20C. Desired amounts were weighed and solubilized in a solution
of 100 mM KCl and 10 mM CaCl2 at pH 6.0.Circular dichroism (CD) spectroscopy
CD experiments were performed using a Jasco J-815 spectrophotometer
fitted with a Peltier temperature control system (Easton, MD). The CD
spectra for the Cx45CT K265-I396 and A333-N361 domains were recorded
in various buffer conditions (Table S1 in the Supporting Material). For each
sample, 5 scans (wavelength range: 300–190 nm; response time: 1 s; scan
rate: 50 nm/min; bandwidth 1.0 nm) were collected using a 0.01 cm quartz
cell and processed using Spectra Analysis (Jasco). Each spectrum shown is
the mean residue ellipiticity (MRE; deg cm2 dmol1) as a function of wave-
length and average of 5 scans. All spectra are corrected by subtracting the
solvent spectrum. Protein concentrations were determined using a Nano-
Drop 1000 (Thermo Scientific; Wilmington, DE) or Biospec 1601 UV-VIS
spectrophotometer (Shimadzu; Carlsbad, CA) at 280 nm. Analyses of
spectra were performed using the Provencher and Glockner method with
the SP175 reference set on the online program DichroWeb (33–36).Analytical ultracentrifugation – sedimentation
equilibrium
Sedimentation equilibrium experiments were performed at 20C with a
Beckman Optima XL-I analytical ultracentrifuge using an AN-50Ti or
AN-60Ti rotor (Beckman Coulter; Indianapolis, IN). For sedimentation
equilibrium, different Cx45CT constructs were analyzed in various buffer
conditions (Table S1). Data were collected at three concentrations
(Abs280nm of 0.3, 0.5, and 0.9) and various rotor speeds. Absorbance scansBiophysical Journal 106(10) 2184–2195
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FIGURE 1 Distribution of the Cx45CT domain at sedimentation equilib-
rium. Absorbance of the Cx45CT domain in 1 PBS buffer at (A) pH 5.8
and (B) pH 7.5 at equilibrium (22,000 rpm) are shown as a function of
radius. The solid lines are the theoretical curves.RESULTS
Dimerization of the Cx45CT domain
Two independent observations suggested the ability of
the Cx45CT domain to oligomerize. First, the 15 kDa
Cx45CT was unable to pass through a 30 kDa molecular
cut off filter, unlike the similar molecular mass Cx43CT
and Cx40CT domains (13,29). Second, a yeast two-hybrid
screen using the Cx45CT domain as bait against a cardiac
cDNA library identified an interaction against itself (data
not shown). Therefore, sedimentation equilibrium experi-
ments were performed to confirm Cx45CT oligomerization,
determine the oligomerization state, and calculate the disso-
ciation constant (KD). Data were collected at either physio-
logical (pH 7.5) or acidic (pH 5.8) conditions. Intracellular
acidification, which is a major consequence of tissue
ischemia during a myocardial infarction, leads to closure,
degradation, and altered expression of gap junction channels
and can be a substrate for malignant ventricular arrhythmias
(2). Plots of optical density at equilibrium as a function of
radius at pH 5.8 and 7.5 at a rotor speed of 22,000 rpm
are shown in Fig. 1, A and B, respectively. Data were
also collected at 18,000 and 26,000 for both pH values
(Fig. S1) and used to analyze the stoichiometry of oligomer-
ization. Each plot was best fit by a function derived from a
self-association model that determined the fraction of
protein in specific oligomeric states (Beckman XL-A/XL-I
software package). The molecular mass values were deter-
mined to be 31,152 Da at pH 5.8 and 31,435 Da at
pH 7.5. A dimer model showed very good convergence as
demonstrated by the minimum deviation in the residuals
(top plot on each panel) and a weighted variance approach-
ing unity (data not shown). In contrast, fits of data to a
monomer, monomer-dimer-trimer, and monomer-dimer-
tetramer model had weighted variance values significantly
greater than one. The results obtained from the dimer modelBiophysical Journal 106(10) 2184–2195were used to calculate the KD (141 nM at pH 5.8 and 97 nM
at pH 7.5). Sedimentation velocity was then used to provide
an independent confirmation of the oligomeric state
(Fig. S2). Two species were discerned for the Cx45CT at
both pH 5.8 and pH 7.5 corresponding to the sedimentation
coefficient distribution c(s) at s20w-values of 2.165 S (major)
and 0.2545 S (minor) at pH 5.8 and 2.045 S (major) and
0.2374 S (minor) at pH 7.5. The molecular mass values of
the major species implied by the average boundary spread
in the sedimentation coefficient distribution c(s) were
32,630 Da at pH 5.8 and 32,604 Da at pH 7.5.Secondary structure of the Cx45CT domain
CD spectroscopy was used to determine which type of
secondary structure mediates Cx45CT dimerization. The
CD spectra of the Cx45CT domain at both pH 5.8 and 7.5
have two peak minima at 206 and 222 nm; however, the
MRE value at 206 nm is more negative than the 222 nm
MRE value (Fig. 2 A). The data are characteristic of a
protein that contains both a-helical and random coil struc-
tures, which was confirmed by Dichroweb analysis
(34–36). The Cx45CT domain at pH 5.8 and 7.5 were
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FIGURE 2 Secondary structure of the Cx45CT domain. (A) CD spectra
of the Cx45CT domain at pH 5.8 and 7.5. CD spectra at (B) pH 5.8 and
(C) pH 7.5 were also obtained in the presence of varying concentrations
of 2,2,2-trifluoroethanol (TFE; % indicated in each panel).
Cx45CT Molecular Interactions 218719% and 18% a-helical, respectively, with the remainder of
the protein being random coiled. CD measurements were
also carried out in various concentrations of the helix-stabi-
lizing cosolvent 2,2,2-Trifluoroethanol (TFE; Fig. 2, B
and C). Increasing the TFE concentrations from 5% to
30% at both pH 5.8 and 7.5 caused a shift in the minima
peaks from 206 nm to 208 nm, a decrease in the 222 nm
values, and an increase in the 195 nm values, which indicate
additional a-helical content. This result suggests that TFE is
stabilizing the innate a-helical structure and/or residues sus-
ceptible to a-helical formation.Characterizing Cx45CT residues A333-N361
The first indication of the residues involved in both dimer-
ization and a-helical structure was derived from the
15N-HSQC spectrum of the Cx45CT domain (27). Uponassignment of the resonances, one region (A333-N361)
had crosspeaks that broadened beyond detection
(Fig. 3 A), suggesting intermediate chemical exchange.
Additionally, the small dispersion of the remaining cross-
peaks in the 15N-HSQC spectrum (%1 ppm) indicated a
lack of secondary structure. Combined, these observations
suggest that the Cx45CT residues A333-N361 contain the
a-helical and may be responsible for the dimeric structure.
These findings were confirmed by characterizing a polypep-
tide corresponding to Cx45CT residues A333-N361. The
CD data indicate that Cx45CT residues A333-N361 are pre-
dominantly a-helical (Fig. 3 B). Sedimentation equilibrium
data revealed that the Cx45CT A333-N361 polypeptide at
pH 5.8 was also dimeric with a significantly increased bind-
ing affinity compared to the full-length Cx45CT (KD ¼ 74
pM, Fig. 3 C and Fig. S3).Disruption of the dimerization domain
To ascertain the noncovalent forces responsible for dimer-
ization within Cx45CT residues A333-N361, a helical wheel
analysis was performed (Fig. 3 D). The data identified a
hydrophobic (L335, I338, I342, A345, and L349) and an
electrostatic (E336, R340, R343, E347, and D350) face.
Therefore, different buffer conditions were screened to
determine the face mediating Cx45CT dimerization (Table
S1). The goal was to compare conditions that disrupt dimer-
ization yet maintain the a-helical structure; highlighted in
bold are solution conditions that met this goal. A common-
ality among them is their ability to disrupt hydrophobic in-
teractions (40–42). Provided in Fig. 4 are the CD and
sedimentation equilibrium data of representative solution
conditions that disrupt either the electrostatic or hydro-
phobic interactions. The Cx45CT domain remains a-helical
in both types of solution conditions but is monomeric in
30% acetonitrile (15,407 Da) and dimeric in 1 M NaCl
(31,782 Da, KD ¼ 242 pM). Using sedimentation velocity,
the sedimentation coefficient distribution c(s) at s20w-values
for the Cx45CT in 30% acetonitrile was 1.155 S (Fig. S4).
The molecular mass implied by the average boundary
spread in the single sedimentation coefficient distribution
c(s) was 15,635 Da, showing that acetonitrile disrupted
Cx45CT dimerization. Interestingly, increasing the concen-
tration of NaCl to 1 M (from 137 mM in 1 PBS) caused an
increase in the binding affinity of the Cx45CT dimer (242
pM vs. 141 nM); this salting out effect is consistent with
dimerization being driven by the hydrophobic interactions.
Similar findings were observed with the Cx45CT A333-
N361 polypeptide.
In the presence of 30% acetonitrile, the Cx45CT A333-
N361 polypeptide also remained a-helical and monomeric
(3,631 Da; Fig. 5, A and B, and Fig. S5). Disruption of
dimerization was evident upon comparison of the 15N-
HSQC spectra collected for the polypeptide in 1 PBS
alone and with 30% acetonitrile at pH 5.8 (Fig. 5 C). TheBiophysical Journal 106(10) 2184–2195
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FIGURE 3 Characterization of the Cx45CT
a-helical and dimerization domain. (A) Schematic
diagram and primary amino acid sequence of the
Cx45CT domain. Highlighted in gray are the resi-
dues not present in the 15N-HSQC spectrum. (B),
CD spectra of the Cx45CT domain: full-length
(K265-I396) and polypeptide (A333-N361). (C)
Sedimentation equilibrium of the Cx45CT poly-
peptide (A333-N361) is shown as a function of
radius at 30,000 rpm. The solid line corresponds
to the theoretical curve. (D) Helical wheel projec-
tion of Cx45CT residues A333-D350 showcases
the hydrophobic and electrostatic faces. Hydro-
philic residues are circles, hydrophobic residues
are diamonds, and charged residues as pentagons.
2188 Kopanic et al.1 PBS solution condition contains only 10 crosspeaks,
whereas all 29 crosspeaks are visible in 30% acetonitrile.
Together with the full-length Cx45CT, the A333-N361 poly-
peptide data strongly suggest dimerization is mediated by
interactions involving the hydrophobic residues.
To determine the orientation of the dimer conformation,
molecular modeling was performed using Cx45CT residues
A333-N361. Initially, a-helical backbone hydrogen bonds
were used as distance constraints of 1.60–2.05 A˚ between
Oi and NHiþ4 and 2.2–3.0 A˚ between Oi and Niþ4 for resi-6.95
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Biophysical Journal 106(10) 2184–2195dues in this segment. Structural models were then calculated
from fully extended starting conformations using the protein
structure calculation program CYANA (43). The 10 lowest
energy structures were inputted into the protein docking
program ZDOCK (44). ZDOCK searches all possible
binding modes in the translational and rotational space be-
tween the two proteins and evaluates each by an energy
scoring function. Of the 10 lowest energy structures, six
were in a parallel and four in an antiparallel conformation.
Next, all hydrogens within 5 A˚ between the two molecules7.00 7.05
ius
7.05 7.10
ius
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FIGURE 4 Identifying solution conditions that
affect the Cx45CT dimer conformation without
altering secondary structure. CD (left) and sedi-
mentation equilibrium (right) data were collected
for the Cx45CT domain in 1 PBS with (A) 30%
acetonitrile or (B) 1 M NaCl at pH 5.8. For sedi-
mentation equilibrium, the absorbances of the
Cx45CT domain at equilibrium (18,000 rpm) are
shown as a function of radius. The solid lines are
the theoretical curves.
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FIGURE 5 Acetonitrile disrupts dimerization of
the Cx45CT polypeptide without altering second-
ary structure. CD (A) and sedimentation equilib-
rium (B) data (A) CD and (B) sedimentation
equilibrium were collected for the Cx45CT poly-
peptide (A333-N361) in 1 PBS with 30% aceto-
nitrile at pH 5.8. For sedimentation equilibrium,
absorbance at equilibrium (30,000 rpm) is shown
as a function of radius. The solid line is the theoret-
ical curve. (C) 15N-HSQC of the Cx45CT polypep-
tide (A333-N361) in 1 PBS (black) and 1 PBS
with 30% acetonitrile (gray) at pH 5.8.
Cx45CT Molecular Interactions 2189were identified for the lowest energy parallel and anti-
parallel conformations (Fig. 6, A and B). Based upon the
number of residues involved (11 vs. 27) and total number
of connectivities (61 vs. 193), the data support a parallel
dimer conformation. Using the modeling software molmol,
the lowest energy parallel dimer structure is illustrated inA B C
FIGURE 6 Intermolecular interactions responsible for Cx45CT dimer-
ization. Displayed is Cx45CT residues A333-N361 in an (A) antiparallel
and (B) parallel configuration. The lines between the Cx45CT domains
represent the number of hydrogen bonds within 5 A˚ between the indicated
residues. Solid lines have >5 connections (<5 have dashed lines). Circled
residues contain >10 total connections. (C) Ribbon diagram of the lowest
energy parallel conformation. To see this figure in color, go online.Fig. 6 C. Additionally, the online program COILS (predicts
coiled-coil regions of proteins and peptides; http://embnet.
vital-it.ch/software/COILS_form.html) predicted with a
high probability (99%) that residues A333-N361 form a
coiled-coil structure. This finding is consistent with the
molecular modeling data as coiled-coil domains are
involved in protein oligomerization.
To provide additional evidence that the hydrophobic face
is mediating Cx45CT dimerization, all residues comprising
the hydrophobic face where substituted (L335E, L338E,
I342E, L349E, I353E, and Y356E). As a control, substitu-
tions were made to residues along the electrostatic face
(E336Q, R340Q, R343Q, E347Q, and D350Q). Both con-
structs maintain a-helical structure (Fig. S6). However,
only substitutions of the hydrophobic residues inhibited
dimerization (Fig. S7, Fig. S8, and Table S2). Altogether,
these data further support that Cx45CT dimerization is
based on hydrophobic interactions.Characterizing the Cx45CT domain interaction
with molecular partners
The identification of proteins that interact with each of the
connexin CT domains has been instrumental toward a better
understanding of gap junction regulation. Yet, as compared
to other isoforms, little information is known about Cx45
molecular partners. Based upon the commonality of cardiac
connexins to express within the same cell and to associate
with ZO-1 (14,15,45–52), we tested if other known Cx43
and Cx40 molecular partners also interact with the
Cx45CT domain (Table S3). 15N-HSQC experiments were
performed with each unlabeled molecular partner titrated
at varying molar ratios into a buffer solution containingBiophysical Journal 106(10) 2184–2195
2190 Kopanic et al.15N-Cx45CT at a constant concentration (100 mM). As con-
trols, 15N-HSQC spectra of the Cx45CT domain were
collected in the presence of increased salt, bovine serum
albumin, or calcium to identify resonances susceptible to
nonspecific effects (Fig. 7 A). The changes in chemical
shifts were plotted as a function of molecular partner con-
centration and fitted using the nonlinear least squares
method to determine the KD of the interactions. An example
titration with the Nedd4 WW2 domain is provided in
Fig. S9. In total, six molecular partners were studied, each
with varying mechanisms to regulate gap junctions. A sum-
mary of the Cx45CT residues affected by each of the molec-
ular partners with the KD values is provided in Fig. 7 B. The
ZO-1 PDZ-2 domain interacted with residues at the
C-terminus of Cx45CT (K371-I396). The remaining molec-
ular partners (c-Src SH3 domain, Nedd4 WW2 domain,
TSG101 UEV domain, Dyn2 PH domain, and CaM) inter-
acted near the N-terminus with varying binding affinities
and between residues L269 and N314.Cx45CT interaction with the Cx43CT and Cx40CT
domains
The existence of heteromeric Cx40/Cx43, Cx45/43, Cx45/
Cx40 connexons, the ability of Cx45CT, Cx43CT, and
Cx40CT to dimerize, and the known interaction between
the Cx43CT and Cx40CT domains suggest possible
hetero-CT interactions involving the Cx45CT domain
(4,13,14,27,29,50–52). To test for hetero-CT dimerization,
15N-HSQC spectra were acquired using unlabeled
Cx40CT or Cx43CT titrated at varying concentrations into
a buffer solution containing 15N-Cx45CT (100 mM). A sum-
mary of the Cx45CT residues affected by the presence
of Cx43CT or Cx40CT are displayed in Fig. 7 C. The
Cx40CTand Cx43CT domains affected residues in a similar
area of the Cx45CT domain and with comparable KD values.
In addition, 15N-HSQC spectra were acquired using 15N-
labeled Cx43CT or Cx40CT (100 mM) with various molar
ratios of unlabeled Cx45CT. The Cx45CT domain affected
Cx43CT residues Y265-L278 and G285-D339 (Fig. 7 D,
top), whereas the affected Cx40CT residues span from
F264-G285, E306-Q316, and Q332-S336 (Fig. 7 E, top).
The KD values are similar to those collected using
15N-
labled Cx45CT. These residues are similar to those previ-
ously described for the interactions between Cx40CT and
Cx43CT (Fig. 7, D and E, bottom; 13, 16, 17, 27).Characterization of the Cx45CT attached to the
4th transmembrane (TM4) domain
The soluble CT domain retains biochemical and functional
properties consistent with those found in a gap junction
plaque (16,17,25). However, when the Cx43CTwas tethered
to its 4th transmembrane domain (TM4-Cx43CT), the over-
all structure and structural responsiveness to stimuli (e.g.,Biophysical Journal 106(10) 2184–2195pH and phosphorylation) were different from the soluble
form (53,54). Therefore, the TM4-Cx45CT and TM4
domain alone were purified and reconstituted in detergent
micelles to characterize the effect of pH on its structure
and to determine if dimerization occurs with this more
native-like construct. The CD spectra for the soluble
Cx45CT, TM4-Cx45CT, and TM4 domains are shown in
Fig. 8. The TM4-Cx45CT had increased a-helical content
(pH 5.8, 28%; pH 7.5, 25%; Fig. 2 A) in comparison to
the soluble Cx45CT (pH 5.8, 19%; pH 7.5, 18%), whereas
the TM4 domain alone was entirely a-helical. The TM4
domain contains ~9% of the total number of amino acids;
combining this a-helical content with the soluble Cx45CT
domain equates to that of the TM4-Cx45CT. Therefore,
tethering the CT domain does not affect the a-helical
content in the Cx45 isoform. Furthermore, the soluble
Cx45CTand TM4 domains alone showminimal to no differ-
ence in secondary structure between the CD spectra
collected at pH 7.5 and pH 5.8, whereas the TM4-
Cx45CT had a small increase of a-helical content under
acidification conditions. These data are different from the
TM4-Cx43CT; the addition of the TM4 residues to the
Cx43CT domain induced a-helical structure in the CT
domain at physiological pH, which significantly increased
upon acidification (53). Of note, LPPG had little-to-no
effect on the Cx45CT secondary structure as determined
by CD (Fig. S10; a-helical content in the presence (20%)
or absence (19%) of LPPG).
Diffusion ordered spectroscopy NMR was used to deter-
mine if the TM4-Cx45CT was in a dimer conformation
when solubilized in LPPG micelles. The diffusion rate of
TM4-Cx45CT in LPPG (4.751 E-11 m2/s) increased in the
presence of 30% acetonitrile (9.002 E-11 m2/s), indicating
that acetonitrile disrupts Cx45CT dimerization. Dynamic
light scattering confirmed this observation, as the hydrody-
namic radius (RH) representing protein was reduced from
144.6 nm to 31.5 nm in the presence of 30% acetonitrile
(Fig. S11 and Table S4). Dynamic light scattering data
also indicated that LPPG micelles remain intact in 30%
acetonitrile only when protein is present in the solution.
This observation, and that acetonitrile affects Cx45CT
dimerization, is consistent with previously published 15N-
HSQC NMR data (28). In the 15N-HSQC spectrum, 30%
acetonitrile was needed to visualize all the crosspeaks.
This is identical to what was observed with the soluble
Cx45CT constructs (27), which are monomeric in 30%
acetonitrile as determined by sedimentation equilibrium
and velocity.DISCUSSION
Biophysical characterization of the Cx45CT identified one
region of a-helical structure flanked by two intrinsically
disordered domains. The a-helical structure mediated
dimerization through hydrophobic contacts. The
AB
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E
FIGURE 7 Summary of the Cx45CT residues affected by different molecular partners. For all panels, the affected CT residues from the 15N-HSQC
experiments are highlighted in gray and titrated partner is labeled on the left of each primary sequence. (A) Cx45CT residues susceptible to shifting by
nonspecific effects (controls). (B) Cx45CT residues affected by each of the molecular partners. (C–E) Cx45CT, Cx43CT, and Cx40CT residues affected
by each other. Data previously published for the Cx43CT/Cx40CT interaction are provided for comparison (13).
Cx45CT Molecular Interactions 2191intrinsically disordered domains interacted with the same
molecular partners as Cx43 and Cx40, as well as their CT
domains. To our knowledge, this study represents the firststructural characterization of the Cx45CT domain alone or
when associated with molecular partners involved in gap
junction regulation. These findings provide insight into theBiophysical Journal 106(10) 2184–2195
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FIGURE 8 Secondary structure of the Cx45CT domain when attached to
its 4th transmembrane domain. CD spectra are overlaid for the soluble
Cx45CT K265-I396 (black), TM4-Cx45CT D219-I396 (dark gray), and
TM4 domain D219-K314 (light gray) at pH 5.8 (solid) and pH 7.5 (dashed).
2192 Kopanic et al.molecular mechanisms involved in the regulation of homo-
meric and heteromeric gap junctional channels.Significance of the CT a-helical structure
In general, the structure of the Cx45, Cx43, and Cx40 CT
domains are predominantly intrinsically disordered with
varying degrees of a-helical content. The Cx40CT domain
is entirely random coiled, albeit one region (C267-G285)
has a propensity to form a a-helix in the presence of TFE
(13). The Cx43CT structure is mostly intrinsically disor-
dered with two short dynamic helical domains (5% total
a-helical content) between A315-T326 and D340-A348
(14). The Cx45CT domain contains the largest amount of
a-helical structure (19% total a-helical content), which is
within one region (A333-N361). Almost no sequence
homology exists between the a-helical residues of the
Cx45CT and Cx43CT domains, yet their a-helical residues
would be similarly located (distance from the membrane).
Residues within the Cx45CT and Cx43CT a-helices
mediate CT homodimerization (27,29). The amount of
a-helical content correlates with the binding affinity for
the homodimer; the Cx45CT binding affinity is ~1000-
fold stronger than that for the Cx43CT domain (pH 5.8,
KD ¼ 141 nM vs. 70 mM, respectively; (13,29)). Our data
indicate that Cx45CT dimerization is mediated by hydro-
phobic residues, potentially through a coiled-coil structure,
as evident by the effects of solution conditions and
mutations that specifically disrupt hydrophobic contacts.
In contrast, no discernible hydrophobic face is evident in a
helical wheel of the two small Cx43CT a-helical domains
that mediate dimerization. We also identified that dimeriza-
tion mediated by Cx45CT hydrophobic face is not pH-
sensitive (97 nM at pH 7.5 and 141 nM at pH 5.8), but the
nonhydrophobic dimerization of Cx43 is pH-sensitive
(29,16). Furthermore, pH-mediated channel closure of
Cx43 involves the CT domain but is not required for pH-Biophysical Journal 106(10) 2184–2195mediated closure of Cx45 channels (13,25,56). Altogether,
the data suggest that CT dimerization plays regulatory roles
in connexin channels, and isoform-specific mechanisms and
effects exist between the different cardiac connexins.
Cx43 and Cx45 can interact to form heteromeric gap
junction channels in heterologous expression systems and
in working ventricular myocytes (4,57–59). The physiolog-
ical consequences of heteromeric gap junction channel
formation on intercellular communication remain unclear;
however, functional studies of heteromeric connexons
show gating and permeability properties that differ from
their homomeric counterparts (60). For example, expression
of Cx45 in cells expressing Cx43 results in a dominant nega-
tive effect of Cx45 characterized by reduced gap junction
conductance and dye transfer (4,59,61,62) without changes
in Cx43 abundance, localization, or phosphorylation (62).
Although the transmembrane domains have been implicated
in the formation and regulation of gap junction channels
(63,21), previous studies and those presented herein would
also suggest involvement of the CT domain in regulation
of heteromeric channels (25,62,65). Our data identified
heterodimerization between the Cx45 and Cx43 CT
domains; the residues involved in heterodimerization differ
than those of homodimerization (Fig. 7, C and D; (13,29)).
Because Cx45 dominates the conduction and dye-transfer
phenotypes of Cx43/Cx45 heteromeric channels (4), the
possibility exists that Cx45CT molecules forming dimers
within the hexameric channels are sufficient to predomi-
nantly mimic a Cx45 channel rather than a Cx43 channel.
Because the binding affinity of a Cx45CT/Cx43CT dimer
is far stronger than that of a Cx43CT homodimer, heterodi-
merization (i.e., involving Cx43 and Cx45 CT domains)
may occur at physiological pH, at which Cx43CT-
Cx43CT dimerization would not occur. In either case, it
would be important to inhibit Cx45CT homo- and heterodi-
merization in heteromeric channels, as our hypothesis
would suggest that channel properties would then more
resemble that of Cx43 homomeric channels.Significance of the CT intrinsically disordered
domains
The other important structural feature of the Cx43, Cx40,
and Cx45 CT domains is that they are all predominantly
intrinsically disordered. The major functions of intrinsically
disordered proteins include protein-protein binding, flexi-
bility, and phosphorylation, which all apply to the CT
domains (66). A disordered CT domain would be ideal for
cell signaling events by allowing many different binding
partners with both high specificity and low affinity to rapidly
switch between molecular partners, thus activating alterna-
tive signaling pathways (66). Numerous studies have identi-
fied molecular partners that interact with the CT domain of
connexins (for review, see (8)). Identical to what was previ-
ously seen with the Cx43CTand Cx40CT domains, all of the
Cx45CT Molecular Interactions 2193molecular partners studied here interacted in the intrinsi-
cally disordered regions of the Cx45CT (Table S5). For
example, the PDZ-2 domain of ZO-1 affected most of the
26 C-terminal residues (K371-I396; KD¼ 9.7 mM), a region
similar to that found in Cx40CT (last 28 residues; KD ¼
27.6 mM) and Cx43CT (last 19 residues; KD ¼ 63 mM)
(14,15). One Cx45CT region (residues Y275-Y290) was
affected by most of the investigated molecular partners.
These include the c-Src SH3, Nedd4 WW2, Dyn2 PH, and
TSG101 UEV domains, which have overlapping sequence
interacting motifs (SH3, PXXP; WW, PPXY; PH, poly-
proline; UEV, P[S/T]AP) within residues P282-Y288
(PSAPPGY). For CaM, a classical binding motif does not
exist in the Cx45CT, suggesting a nontraditional binding
motif similar to what was observed for Cx32CT (67,68).
In general, the location and cellular conditions, along with
post-translational modifications, will dictate which protein
associates with the CT domain. We also identified that
residues within this Cx45CT domain (P278-P285) undergo
cis-trans proline isomerization (27). Previous reports identi-
fied that cis-trans proline isomerization can modulate pro-
tein-protein interactions (69). Although cis-trans proline
isomerization has not been identified experimentally to
occur for any other connexin CT domain, upon comparing
the primary sequences, similarities exist between the CT
domains of all identified cardiac connexins: Cx45 Y275-
Y290, Cx43 S272-Y286, Cx40 P251-F265, Cx37 P266-
Y279, and Cx30.2 P228-Y245 (Fig. 9). The online program
CISPEPpred (sunflower.kuicr.kyoto-u.ac.jp/~sjn/cispep)
predicted that all of these CT regions, except Cx43, can un-
dergo cis-trans proline isomerization. Finally, this region
within Cx43CT (S272-Y286) contains known sites of phos-
phorylation by MAPK, which decreases gap junction inter-
cellular communication and modulates protein-proteinFIGURE 9 Schematic of the cardiac connexins’ master regulatory
domain. The proposed Cx45CT, Cx43CT, Cx40CT, Cx37CT, and Cx30.2
master regulatory domains are denoted by the brackets. The overlapping
molecular partner sequence motifs are highlighted by the ovals. Sites of
phosphorylation (circles above sequences) and cis-trans proline isomeriza-
tion (rectangles) are indicated. Experimental data, solid lines; predicted
data, dashed lines.interactions (i.e., Nedd4). Using the NetPhosK 1.0 server
(www.cbs.dtu.dk/services/NetPhosK), the other cardiac
connexins were predicted to also be phosphorylated within
these regions (70). We propose that these CT residues
constitute a master regulatory domain, an intrinsically dis-
ordered region that has known (or predicted) sites of
phosphorylation, ability to undergo cis-trans proline isom-
erization, and overlapping sequence motifs that enables
binding with multiple molecular partners (14,15).
The CT domain of connexins contains many functionally
important sites, notably those involved in channel gating,
phosphorylation, and protein-protein interactions. As a key
player in the regulation of gap junctions, the CT presents
itself as a target for manipulation intended to modify func-
tion. Cx45 is predominately expressed in the specialized
myocytes of the impulse generation and conduction system.
In both ventricular and atrial human working myocardium,
Cx45 is present in very low quantities; however, a reduction
in ventricular Cx43 coupled with increased Cx45 protein
levels has been observed after myocardial infarction and
end-stage heart failure. Cx45 may influence electrical and/
or metabolic coupling as a result of pathophysiological
over-expression. A target would be to modify the behavior
of the Cx45 channel to restore function (e.g., attenuate
Cx45 dimerization to resemble Cx43 channels); this may
prove valuable in the clinical management of arrhythmias
in heart failure. The information provided from this and other
studies will help build the foundation for the design of the
next generation of chemical modifiers to achieve this goal.SUPPORTING MATERIAL
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